Gw&K Investment Management, LLC Dbv Technologies S.A. Transaction History

Gw&K Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$5.75 - $21.85 $783,679 - $2.98 Million	-136,292 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$16.81 - $24.58 $44,781 - $65,481	-2,664 Reduced 1.92%	136,292 $3.06 Million
Q2 2018 Aug 07, 2018	SELL	$18.6 - $24.94 $31,285 - $41,949	-1,682 Reduced 1.2%	138,956 $2.68 Million
Q1 2018 May 08, 2018	BUY	$20.86 - $26.6 $46,872 - $59,770	2,247 Added 1.62%	140,638 $3.25 Million
Q4 2017 Jan 19, 2018	BUY	$20.9 - $49.36 $809,352 - $1.91 Million	38,725 Added 38.85%	138,391 $3.4 Million
Q3 2017 Oct 11, 2017	BUY	$39.62 - $46.17 $3.95 Million - $4.6 Million	99,666	99,666 $4.23 Million

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $933M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gw&K Investment Management, LLC with notifications on news.